431 related articles for article (PubMed ID: 26701983)
1. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
[TBL] [Abstract][Full Text] [Related]
2. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
3. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.
Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2018 May; 32(11):fj201800237R. PubMed ID: 29775417
[TBL] [Abstract][Full Text] [Related]
4. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.
Yu C; Xiong C; Tang J; Hou X; Liu N; Bayliss G; Zhuang S
Theranostics; 2021; 11(6):2706-2721. PubMed ID: 33456568
[No Abstract] [Full Text] [Related]
6. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway.
Lin P; Qiu F; Wu M; Xu L; Huang D; Wang C; Yang X; Ye C
Pharm Biol; 2023 Dec; 61(1):23-29. PubMed ID: 36524761
[TBL] [Abstract][Full Text] [Related]
8. EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation.
Jarome TJ; Perez GA; Hauser RM; Hatch KM; Lubin FD
J Neurosci; 2018 Aug; 38(35):7635-7648. PubMed ID: 30030400
[TBL] [Abstract][Full Text] [Related]
9. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
[TBL] [Abstract][Full Text] [Related]
10. Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2.
Xu L; Gao J; Huang D; Lin P; Yao D; Yang F; Zhang Y; Yang X; Wu M; Ye C
Biochem Biophys Res Commun; 2021 Jan; 534():279-285. PubMed ID: 33288199
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
Zhu Y; Yu C; Zhuang S
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
[TBL] [Abstract][Full Text] [Related]
12. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
[TBL] [Abstract][Full Text] [Related]
13. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
[TBL] [Abstract][Full Text] [Related]
14. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.
Liu L; Liu F; Guan Y; Zou J; Zhang C; Xiong C; Zhao TC; Bayliss G; Li X; Zhuang S
FASEB J; 2021 Jul; 35(7):e21715. PubMed ID: 34143514
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
[TBL] [Abstract][Full Text] [Related]
16. Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism.
Tao S; Yang L; Wu C; Hu Y; Guo F; Ren Q; Ma L; Fu P
Phytomedicine; 2022 Nov; 106():154390. PubMed ID: 35994849
[TBL] [Abstract][Full Text] [Related]
17. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
18. O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis.
Fang N; Li P
Life Sci; 2021 Jun; 274():119226. PubMed ID: 33609540
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EZH2 ameliorates hyperoxaluria-induced kidney injury through the JNK/FoxO3a pathway.
Gao X; Peng Y; Fang Z; Li L; Ming S; Dong H; Li R; Zhu Y; Zhang W; Zhu B; Liao J; Wang Z; Liu M; Li W; Zeng J; Gao X
Life Sci; 2022 Feb; 291():120258. PubMed ID: 34952043
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
Wan SS; Pan YM; Yang WJ; Rao ZQ; Yang YN
FASEB J; 2020 Aug; 34(8):10168-10181. PubMed ID: 32562311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
